<DOC>
	<DOCNO>NCT02695277</DOCNO>
	<brief_summary>This prospective , randomize ( 2:1 ) multicenter trial investigate optimal treatment Persistent Longstanding Persistent AF refer Radiofrequency ( RF ) ablation.The study objective compare efficacy safety two interventional approach , prevent recurrence AF symptomatic , drug refractory patient persistent longstanding persistent atrial fibrillation .</brief_summary>
	<brief_title>Combined Endoscopic Epicardial Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation Persistent Longstanding Persistent Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Patient history symptomatic Persistent AF leave atrium ( LA ) &gt; 4cm Long Standing Persistent AF define HRS/EHRA/ECAS expert consensus statement 2 . Patient refractory intolerant least one antiarrhythmic drug ( class I III ) 3 . Patient mentally able willing give inform consent 1 . Patient longstanding persistent AF &gt; 10 year 2 . Patient present paroxysmal AF 3 . Patient persistent AF LAdiameter â‰¤ 4cm 4 . AF secondary electrolyte imbalance , thyroid disease , reversible noncardiovascular cause 5 . Patient underwent previous ablation procedure heart surgery 6 . Patient need cardiac surgery procedure besides AF treatment ( valve , coronary , others ) 7 . Contraindication either catheter ablation epicardial surgery ( include , limited : previous thoracic radiation , previous perimyocarditis , Previous cardiac tamponade , Pleural adhesion , Prior thoracotomy ) 8 . Body mass index &gt; 35 9 . LA Diameter &gt; 6 cm 10 . Left ventricular ejection fraction &lt; 30 % 11 . Severe mitral regurgitation ( &gt; II ) 12 . Patient unable undergo TransEsophageal Echocardiogram ( TEE ) 13 . Presence LA thrombus TEE , CT scan , MRI angiography 14 . History cerebrovascular disease , include stroke transient ischemic attack ( TIA ) within 6 month prior enrollment 15 . Active infection sepsis 16 . Other clinical condition preclude inclusion ( e.g. , organ disease , disturbances hemostasis ) 17 . Contraindication anticoagulant therapy , inability comply anticoagulant therapy 18 . Pregnancy , plan pregnancy breastfeed 19 . Life expectancy le 12 month 20 . Patient involve another study involve investigational drug device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Persistent Longstanding Persistent AF</keyword>
	<keyword>Hybrid Procedure</keyword>
	<keyword>Catheter Ablation</keyword>
</DOC>